Page last updated: 2024-09-03

imatinib mesylate and Leukemia, Lymphocytic, T Cell

imatinib mesylate has been researched along with Leukemia, Lymphocytic, T Cell in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Keersmaecker, K	1
Burbury, K; Catalano, A; Chew, LP; Seymour, JF; Westerman, D	1
Cools, J; De Keersmaecker, K; Graux, C; Hagemeijer, A; Maertens, J; Marynen, P; Mentens, N; Odero, MD; Somers, R; Vandenberghe, P; Wlodarska, I	1

Reviews

1 review(s) available for imatinib mesylate and Leukemia, Lymphocytic, T Cell

Article	Year
ABL1 fusions in T-cell acute lymphoblastic leukemia. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 2008, Volume: 70, Issue:4 Topics: Benzamides; Genes, abl; Humans; Imatinib Mesylate; Leukemia, T-Cell; Nuclear Pore Complex Proteins; Oncogene Proteins, Fusion; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2008

Other Studies

2 other study(ies) available for imatinib mesylate and Leukemia, Lymphocytic, T Cell

Article	Year
Concomitant FIP1L1-PDGFRA fusion gene and T-cell clonality in a case of chronic eosinophilic leukemia with clonal evolution and an incomplete response to imatinib. Leukemia & lymphoma, 2011, Volume: 52, Issue:2 Topics: Aged; Antineoplastic Agents; Benzamides; Cell Lineage; Chronic Disease; Clone Cells; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, T-Cell; Male; mRNA Cleavage and Polyadenylation Factors; Mutation; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Treatment Outcome	2011
Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). Blood, 2005, Jun-15, Volume: 105, Issue:12 Topics: Adolescent; Base Sequence; Benzamides; Blotting, Western; Cell Line; Cell Survival; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 9; Cyclin-Dependent Kinase Inhibitor p16; DNA-Binding Proteins; DNA, Complementary; Female; Fusion Proteins, bcr-abl; Gene Deletion; Genes, abl; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, T-Cell; Microtubules; Milk Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Genetic; Molecular Sequence Data; Oncogene Proteins, Fusion; Open Reading Frames; Phenotype; Phosphorylation; Piperazines; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Pyrimidines; Recombinant Fusion Proteins; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; STAT5 Transcription Factor; Time Factors; Trans-Activators; Translocation, Genetic	2005

Article

Year

Concomitant FIP1L1-PDGFRA fusion gene and T-cell clonality in a case of chronic eosinophilic leukemia with clonal evolution and an incomplete response to imatinib.

Leukemia & lymphoma, 2011, Volume: 52, Issue:2

Topics: Aged; Antineoplastic Agents; Benzamides; Cell Lineage; Chronic Disease; Clone Cells; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, T-Cell; Male; mRNA Cleavage and Polyadenylation Factors; Mutation; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Treatment Outcome

2011

Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).

Blood, 2005, Jun-15, Volume: 105, Issue:12

Topics: Adolescent; Base Sequence; Benzamides; Blotting, Western; Cell Line; Cell Survival; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 9; Cyclin-Dependent Kinase Inhibitor p16; DNA-Binding Proteins; DNA, Complementary; Female; Fusion Proteins, bcr-abl; Gene Deletion; Genes, abl; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, T-Cell; Microtubules; Milk Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Genetic; Molecular Sequence Data; Oncogene Proteins, Fusion; Open Reading Frames; Phenotype; Phosphorylation; Piperazines; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Pyrimidines; Recombinant Fusion Proteins; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; STAT5 Transcription Factor; Time Factors; Trans-Activators; Translocation, Genetic

2005